ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Angong Niuhuang Wan for Stroke
To evaluate the efficacy and safety of using Chinese Medicine Angong Niuhuang Wan in stroke patients, the modified Rankin Scale (mRS) score will be used as primary outcome, the National Institutes of Health Stroke Scale (NIHSS) score, The Modified Barthel Index (MBI) score and the Montreal Cognitive Assessment (MoCA) scores will be used as secondary outcome measures.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Urdu Translation of Wayfinding Questionnaire for Stroke Patients#876575
- Patient centered outcomes in stroke: utility-weighted modified Rankin Scale results in a community-based study#477387
- European stroke organisation guideline on stroke-associated pneumonia.#161883
- Risk reduction of cognitive decline and dementia: WHO guidelines: web annex J: evidence profile and evidence-to-decision table for management of stroke#373061
- Pilot of a New Cognitive Assessment Tool for Detecting Dementia in the Migrant Somali Population#871804
Record · ID 1087541
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive